Cargando…
Targeting metabotropic glutamate receptor 4 for cancer immunotherapy
In this study, we report a novel role of metabotropic glutamate receptor 4 (GRM4) in suppressing antitumor immunity. We revealed in three murine syngeneic tumor models (B16, MC38, and 3LL) that either genetic knockout (Grm4(−/−)) or pharmacological inhibition led to significant delay in tumor growth...
Autores principales: | Wan, Zhuoya, Sun, Runzi, Liu, Yang-Wuyue, Li, Sihan, Sun, Jingjing, Li, Jiang, Zhu, Junjie, Moharil, Pearl, Zhang, Bei, Ren, Pengfei, Ren, Guolian, Zhang, Min, Ma, Xiaochao, Dai, Shuangshuang, Yang, Da, Lu, Binfeng, Li, Song |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664261/ https://www.ncbi.nlm.nih.gov/pubmed/34890233 http://dx.doi.org/10.1126/sciadv.abj4226 |
Ejemplares similares
-
Concerted conformational changes control metabotropic glutamate receptor activity
por: Lecat-Guillet, Nathalie, et al.
Publicado: (2023) -
Amphiregulin couples IL1RL1(+) regulatory T cells and cancer-associated fibroblasts to impede antitumor immunity
por: Sun, Runzi, et al.
Publicado: (2023) -
Genome-wide gain-of-function screening characterized lncRNA regulators for tumor immune response
por: Wang, Yifei, et al.
Publicado: (2022) -
The anti-fibrotic drug pirfenidone inhibits liver fibrosis by targeting the small oxidoreductase glutaredoxin-1
por: Xi, Yue, et al.
Publicado: (2021) -
Metabotropic glutamate receptor 5 deficiency inhibits neutrophil infiltration after traumatic brain injury in mice
por: Yang, Ting, et al.
Publicado: (2017)